Table 5.
Demographic and clinical characteristics of patients in the RSV, RSV subgroups (A/B), and RSV genotype groups from 2009 to 2014
| Demographic information (n = 183) | Clinical information (n = 183) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Female/male | Female (%) | Median age (years) | Age group | Clinical symptoms | ||||||||
| 0–2 years | 3–6 years | 7–19 years | 20–49 years | 50–64 years | Over 65 years | Fever | Cough | Sore throat | ||||
| RSV (n = 183) | 81/102 | 44·3 | 2·0 | 116 (63·4) | 58 (31·7) | 6 (3·3) | 1 (0·5) | 1 (0·5) | 1 (0·5) | 159 (86·9) | 154 (84·2) | 37 (20·2) |
| RSV-A (n = 142) | 59/82 | 41·8 | 2·0 | 94 (66·2) | 42 (29·6) | 5 (3·5) | 1 (0·7) | 0 | 0 | 129 (90·8)) | 125 (88·0) | 30 (21·1) |
| ON1 genotype (n = 61) | 31/29 | 51·7 | 2·0 | 35 (57·4) | 24 (39·3) | 1 (1·6) | 1 (1·6) | 0 | 0 | 60 (98·4) | 57 (93·4) | 14 (23·0) |
| NA1 genotype (n = 66) | 23/43 | 34·8 | 1·5 | 49 (74·2) | 13 (19·4) | 4 (6·0) | 0 | 0 | 0 | 57 (86·4) | 56 (84·8) | 12 (18·2) |
| GA1 genotype (n = 1) | 0/1 | 0 | 2·0 | 1 (100·0) | 0 | 0 | 0 | 0 | 0 | 1 (100·0) | 1 (100·0) | 0 |
| GA5 genotype (n = 3) | 0/3 | 0 | 1·0 | 3 (100·0) | 0 | 0 | 0 | 0 | 0 | 1 (33·3) | 1 (33·3) | 0 |
| RSV-B (n = 34) | 19/15 | 55·0 | 3·0 | 16 (47·1) | 15 (44·1) | 1 (2·9) | 0 | 1 (2·9) | 1 (2·9) | 26 (76·5) | 26 (76·5) | 9 (26·5) |
| BA9 genotype (n = 29) | 15/14 | 51·7 | 2·0 | 15 (51·7) | 11 (37·9) | 1 (3·4) | 0 | 1 (3·4) | 1 (3·4) | 21 (72·4) | 21 (72·4) | 7 (24·1) |
| BA10 genotype (n = 2) | 2/0 | 100 | 3·0 | 1 (50·0) | 1 (50·0) | 0 | 0 | 0 | 0 | 2 (100·0) | 2 (100·0) | 1 (50·0) |